Viking Therapeutics, Inc. (VKTX)
NCM · Common · CUSIP 92686J106
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for VKTX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
92686J106
Market Cap
Small Cap · $454 Million
IPO
4/28/2015 · $8.00/share
Business: Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders.

Company Contact

CEO
Brian Lian, Ph.D.
CFO
Greg Zante
Headquarters
12340 El Camino Real, Suite 250, San Diego, CA 92130
Phone
858-704-4660
Investor Relations
Stephanie Diaz, Vida Strategic Partners · 415-675-7401 · sdiaz@vidasp.com
General Email
info@vilingtherapeutics.com
SEC EDGAR Filings
View filings »